The lymphoid cell surface receptor NTB-A: A novel monoclonal antibody target for leukaemia and lymphoma therapeutics

British Journal of Haematology

Volumn 137, Issue 4, 2007, Pages 307-318

  Korver, Wouter ^a   Singh, Shweta ^a   Liu, Shouchun ^a   Zhao, Xiaoxian ^b   Yonkovich, Shirlee ^a   Sweeney, Allison ^a   Anton, Kristin ^a   Lomas III, Woodrow E ^a   Greenwood, Rachel ^a   Smith, Ashley ^a   Tran, Denise Hoang ^a   Shinkawa, Pauline ^a   Jimenez, Mark ^a   Yeung, Patricia ^a   Aguilar, Gerard ^a   Palencia, Servando ^a   Vatta, Paolo ^a   Mueller, Matthew ^a   Zhan, Xiaoming ^a   Newton, Elizabeth M ^a   Liu, Yi ^a   Zhao, Jingsong ^a   Emtage, Peter ^a   Levy, Michael D ^a   Hsi, Eric D ^b   Funk, Walter D ^a   Abo, Arie ^a   more..

^a Nuvelo Inc   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chronic lymphocytic leukaemia; Immunotherapy; Leukaemia; Lymphoma; Monoclonal antibody

Indexed keywords

CELL SURFACE RECEPTOR; MONOCLONAL ANTIBODY; SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE 6; SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE 6 ANTIBODY; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER IMMUNOTHERAPY; CANCER PATIENT; CELL ISOLATION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TARGETING; EMBRYO; EPITOPE MAPPING; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; LYMPHOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RNA INTERFERENCE; SCID MOUSE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, CD; ANTIGENS, NEOPLASM; B-LYMPHOCYTES; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; HYBRIDOMAS; IMMUNIZATION, PASSIVE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOCYTE ACTIVATION; MICE; MICE, NUDE; MICE, SCID; NEOPLASM TRANSPLANTATION; RECEPTORS, CELL SURFACE; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 34247477764     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06569.x     Document Type: Article

References (21)

1. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. Struhl, K. (eds.) (2005) Current Protocols in Molecular Biology. John Wiley & Sons, Hoboken, NJ.
2. Bonifacino, J.S., Dasso, M., Harford, J.B., Lippincott-Schwartz, J. Yamada, K.M. (eds.) (2003) Current Protocols in Cell Biology. John Wiley & Sons, Hoboken, NJ.
3. Bottino, C., Falco, M., Parolini, S., Marcenaro, E., Augugliaro, R., Sivori, S., Landi, E., Biassoni, R., Notarangelo, L.D., Moretta, L. Moretta, A. (2001) NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. Journal of Experimental Medicine, 194, 235 246.
4. Byrd, J.C., Stilgenbauer, S. Flinn, I.W. (2004) Chronic lymphocytic leukemia. Hematology (American Society of Hematology Education Program), 1, 163 183.
5. Canziani, G.A., Klakamp, S. Myszka, D.G. (2004) Kinetic screening of antibodies from crude hybridoma samples using Biacore. Analytical Biochemistry, 325, 301 307.
6. Cao, E., Ramagopal, U.A., Fedorov, A., Fedorov, E., Yan, Q., Lary, J.W., Cole, J.L., Nathenson, S.G. Almo, S.C. (2006) NTB-A receptor crystal structure: insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family. Immunity, 25, 559 570.
7. Eissmann, P. Watzl, C. (2006) Molecular analysis of NTB-A signaling: a role for EAT-2 in NTB-A-mediated activation of human NK cells. Journal of Immunology, 177, 3170 3177.
8. Green, J.M., Karpitskiy, V., Kimzey, S.L. Shaw, A.S. (2000) Coordinate regulation of T cell activation by CD2 and CD28. Journal of Immunology, 164, 3591 3595.
9. Hernandez-Ilizaliturri, F.J., Reddy, N., Holkova, B., Ottman, E. Czuczman, M.S. (2005) Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model. Clinical Cancer Research, 11, 5984 5992.
10. Hopkin, M. (2006) Can super-antibody drugs be tamed? Nature, 440, 855 856.
11. Howie, D., Laroux, F.S., Morra, M., Satoskar, A.R., Rosas, L.E., Faubion, W.A., Julien, A., Rietdijk, S., Coyle, A.J., Fraser, C. Terhorst, C. (2005) Cutting edge: the SLAM family receptor Ly108 controls T cell and neutrophil functions. Journal of Immunology, 174, 5931 5935.
12. Kohler, G. Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 256, 495 497.
13. Kokhaei, P., Palma, M., Mellstedt, H. Choudhury, A. (2005) Biology and treatment of chronic lymphocytic leukemia. Annals of Oncology, 16 (Suppl. 2 ii113 123.
14. Kreitman, R.J., Wang, Q.C., FitzGerald, D.J. Pastan, I. (1999) Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeys. International Journal of Cancer, 81, 148 155.
15. Kuriakose, P. (2005) Targeted therapy for hematologic malignancies. Cancer Control, 12, 82 90.
16. McManaway, M.E., Marti, G.E., Tosato, G., Liu, A.K., al-Nasser, A.A., Kiwanuka, J. Magrath, I.T. (1993) Heterotransplantation of human Burkitt's lymphoma cell lines in athymic nude mice: tumor-host relationships. Pathobiology, 61, 164 172.
17. Ortin, M. (2005) Immunotherapy of hematological malignancies: what is new? Annals of Oncology, 16 (Suppl. 2 ii53 62.
18. Ravandi, F. O'Brien, S. (2005) Alemtuzumab. Expert Review of Anticancer Therapy, 5, 39 51.
19. Robinson, J.P., Darzynkiewicz, Z., Dobrucki, J., Hyun, W., Nolan, J., Orfao, A. Rabinovitch, P. (eds.) (2006) Current Protocols in Cytometry. John Wiley & Sons, Hoboken, NJ.
20. Valdez, P.A., Wang, H., Seshasayee, D., van Lookeren Campagne, M., Gurney, A., Lee, W.P. Grewal, I.S. (2004) NTB-A, a new activating receptor in T cells that regulates autoimmune disease. Journal of Biological Chemistry, 279, 18662 18669.
21. Veillette, A. (2006) Immune regulation by SLAM family receptors and SAP-related adaptors. Nature Reviews Immunology, 6, 56 66.